
--- Page 1 ---
UUID:9529CF47-D435-4CA9-B8B4-069CA2FCD3CD TCGA-CC-A3M9-01A-PR Redacted Irb approved Form Revised Clinical Case Report (For Collection of Cancerous Tissue) Ics-u-3 Criteia Sit: lin c22.0 1/312 s PrimaryNote QUALIFIED ISQUALiFIE Informed Consent I personally informed this patient that a specimen(s) would be collected to be used for research. purposes.I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Name of Physician or Study Coordinator Signature Dale Clinical Information GENERAL INFORMATION Date of Birth (mm/dd/yyy) Height Marital Status Race T-mperature  SinglexIMarried Gender Weight  Divorced  Widow Bkood Pressured Heart Rate Male  Female HISTORY OF PRESENT ILLNESS Symptoms: Wei ghif. Coss Clinical Findings:. Performance Scale (Karnofsky Score):  100 Asymptomatic  80-90 Symptomatic but Fully Ambulatory  60-70 Symptomatic, in bed less than 50% of day  40-50 Symptomatic, in bed more than 50% of day, but not bed ridden   20-30 Bed Ridden CURRENT MEDICATIONS Drug Dose  Route Frequency Date (mm/dd/yyyy) / To / To 1 To 1 To / To

--- Page 2 ---
PAST MEDICAL HISTORY  Diagnosis/Disease/Disorder/Injury  Diagnosis Date Treatment Status OB/GYN HISTORY Menopausal Status Date of First Menses # of Pregnancies  Pre-menopausal  Peri-Menopausal Date of Last Menses # of Live Births  Post-menopausal Birth Control:  Condom Oral Contraceptive IUD  Hormone Replacement  Other: Therapy: SOCIAL HISTORY:  ... Occupation: Environmental Hazards: Smoking History Current Status TypE Packs/day. Duration When Quit LeTAcus S/YES  NO (yrs)  (vr) Alcohol Consumption Current Status TYPE Drinks/day Duration When Quit  donk [?a) YES J nO 1D (yrs) (yr Drug Use TyPE Frequency Duration When Quit Current Status  YES NO (vs) (x) :..* FAMILY MEDICALHISTORY Relative  Diagnosis Age of Diagnosis. LAB DATA Result Test Result Date Test Date HIV Negative  Positive: CEA  Negative  Positive: Hep B  Positive: CA 15-3  Negative  Positive: Negative Hep C CA 19-9 EDNegative  Positive:  Negative  Positive: AFP  PSA   Negative  Positive: Negative  Positive: Other: Other:  Negative  Positive:  Negative  Positive: B/T Cell Markers: 2

--- Page 3 ---
DIAGNOSTIC STUDIES Study Results Date Ultrasound  A t msus Way fouse! Ho live X-Ray CT Endoscopy MRI Biopsy CLINICAL DIAGNOSIS  : Preoperative Clinical Diagnosls Location of Suspected Involved Lymph Nodes. Location of Suspected Distant Metastasis. Clinical Staging Date of Diagnosis t3 No mo Stage: IIL A Treatment Information  SURGICAL TREATMENT: Procedure Date of Procedure Perecta^m Ds asht Lives.. 0 Primary Tumor 1 Organ Detalled Location Size liyek EunersR RjgFi7 LiseR [5 xL x 3 cm Extension of Tumor Lymph Nodes Description Location of Lymph Nodes # of Lymph Nodes Palpable, Non-Dissected Lymph Nodes. Dissected Lymph Nodes Distant Metastasis  Organ Detaiied Location Size Surgical Staging NO m O Stage: L NEOADJUVENT THERAPY (Chemo, Radistion, Immuno, Hormonal, or Molocular) Drug/Treatment Dose Route Frequency Date (mm/dd/yyyy) To To / 1 1 To 1 1 1 / To 1 / 1 To 3

--- Page 4 ---
Pathology Form Specimen Information Collected by: Date: Time: Preserved by: Date Time: SPECIMEN TYPE (# of samples provided) . Frozen Paraffin Biock Blood/Serum/Piasms Slide Diseased  Normal Diseased Normal Diseased Normal Diseased Normal 4 2 4 2 4 2 Time to LN2 Time to Formalin Time to LN2 min min min PATHOLOGICAL DESCRIPTION : Primary Tumor Organ  Size Extension of Tumord Distance to NAT livee TemiR 5x+x3 cm Lver 6 Ri cm Lymph Nodes Location # Examined # Metastasized Distant Metastasis  Organ Detailed Location Size Pathological Staging No m o pT 3 Stage: Notes: 4

--- Page 5 ---
Microscopic Descriotion Histo logical Patter  a Cell Distribution +. Structural Pattem +  Diffuse  Streaming  Mosaic  Storiform Necrosis Fibrosis Lymphocytic Infiltration  Palisading Vascular Invasion Cystic Degeneration Clusterized Bleeding Alveolar Formation Myxoid Change  Indian File  Psammoma/Cakification Cellnlar Differentiation?? Squamous + Adenomatous -  Sarcomatous + Lymphomatous  Squamoid Cell Glandular cell x Round Cell  Large Cell Spindle Cell Cell Stratification. Fibroblast Small Cell Keratin Secretion Osteoblast RS Cell/RS Like  Desmosome Intracyt. Vacuole  Lipoblast Inflam. Cell  Pear!  Gland formation Myoblast  Plasma Cell Cellular Differentiation: Well Moderate  Poor Nuclear Appearance+ ae* Nuclear Atypia: 0 I II III  Aniso Nucleosis x Hyperchromatism Nucleolar Prominent  Multinucleated Giant Cell x Mitotic Activity Nuclear Grade: IHC Datas it Marker Result Value Date ER  Negative  Positive PR  Negative Positive  Her-2/neu Negative  Positive B-Cell Marker  Negative  Positive T-Cell Marker  Negative  Positive Other:  Negative Positive Other: Negative  Positive Final Pathology Report Histological Diagnosis: tedoTeceero nm lifHenouFi'cn(icd!) pT3NpWr Grade:3. Comments: incipal Investigator "Pathologist Date 5

--- Page 6 ---
COnsOLIdateD DIAgnOsTIC pathoLOgy fOrm* Microscopic Appearance: Histological pattern: . CELL DISTRIBUTION Diffuse t STRUCTURALPATTERN X Streaming + Mosaic Storiform Necrosis Fibrosis Lymphocytic Infiltration Palisading Vascular Invasion Cystic Degeneration Clusterized X Bleeding Alveolar Formation Myxoid Change Indian File Psanmoma/Calcification 2. Celiular features: Squamous Adenomatous + Sarcomatous Lymphomatous Squamoid Cell Glandular cell Round Cell Large Cell Spindle Cell x Cell Stratification X Fibroblast Small Cell  Keratin Secretion Osteoblast RS CcIV/RS Like  Desmosome Intracyt. Yacuole Lipoblast Inflam. Cell  Peart  Gland formation  Myoblast Plasma Cell Otherwise Specified: D 207 Dr 70% P37Y by 7O7j D seeesks *s 2.Cellular Differentiation: Well Moderaicly Nuclear Atypia: Nuckar Appearance 11 Aniso Nucleosis X Hyperchromatism .4  Nucleolar Prominent Multinucleated Giant Cell Mitotic Activity Nuckear Grade /e. Histological Diagnosis: Hene tocel/er las C@ndosra Sp'sd Comments: Date Director, Research Pathology 'ATHOLOGIST STAFF FOR RESEARCH USE ONLY). *(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AND